BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22681167)

  • 1. Epigenetics, depression and antidepressant treatment.
    Menke A; Klengel T; Binder EB
    Curr Pharm Des; 2012; 18(36):5879-89. PubMed ID: 22681167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations in depression and antidepressant treatment.
    Menke A; Binder EB
    Dialogues Clin Neurosci; 2014 Sep; 16(3):395-404. PubMed ID: 25364288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modifications of Major Depressive Disorder.
    Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
    Paoli C; Misztak P; Mazzini G; Musazzi L
    Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
    Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
    Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epigenetic mechanisms in major depression].
    Paslakis G; Bleich S; Frieling H; Deuschle M
    Nervenarzt; 2011 Nov; 82(11):1431-2, 1434-8. PubMed ID: 21264459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
    Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
    Deussing JM; Jakovcevski M
    Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation in Major Depressive Disorder.
    Pishva E; Rutten BPF; van den Hove D
    Adv Exp Med Biol; 2017; 978():185-196. PubMed ID: 28523547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epigenetic mechanism of major depression].
    Morinobu S
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1101-12. PubMed ID: 24450142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models.
    Chistiakov DA; Bobryshev YV; Chekhonin VP
    Curr Pharm Des; 2017; 23(44):6828-6840. PubMed ID: 29086676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in major depressive disorder: From pathophysiology to therapy.
    Gonda X; Petschner P; Eszlari N; Baksa D; Edes A; Antal P; Juhasz G; Bagdy G
    Pharmacol Ther; 2019 Feb; 194():22-43. PubMed ID: 30189291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
    Islam F; Gorbovskaya I; Müller DJ
    Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.
    Noordam R; Avery CL; Visser LE; Stricker BH
    Pharmacogenomics; 2016 Jun; 17(9):1029-40. PubMed ID: 27248517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.